The cell harvesting systems market is likely to upscale from US$ 6.3 billion in 2022 to US$ 19.1 billion by 2032. Demand is likely to rise at a significant CAGR of 12.6% during the forecast period.
The demand for cell harvesting and bone marrow transplantation therapy is projected to increase as the prevalence of blood illnesses, such as blood cancer, rises. Additionally, 174,250 people in the United States are anticipated to receive a lymphoma, leukemia, or myeloma diagnosis in 2018, according to a study done by the Leukemia & Lymphoma Society.
The market is benefited from the growing understanding of the advantages of stem cells and how they might be used to treat diseases.
However, during the forecast period, the market expansion is anticipated to be constrained by ethical concerns surrounding embryonic stem cells and unlicensed stem cell therapy offered by healthcare providers in uncontrolled regions like Latin America and Asia Pacific.
Moreover, the cell harvesting systems market is very competitive, with several companies selling comparable goods. Companies may find it challenging to differentiate themselves and obtain a competitive edge as a result.
“The accelerating trend of transplantation and the increasing need for stem cell banking are further factors contributing to the expansion of the cell harvesting systems market.”
The process of separating the cells from the substance in which they are multiplied by filtering or centrifugation method and extracting the desired cells from the growth medium is known as cell harvesting. A powerful and controlled system called a cell harvesting system is used to extract live cells from bioreactors. To be a closed system, it is ideal for collecting seed cells for increasing without needing to be concerned about contamination.
| Attributes | Details |
|---|---|
| Cell harvesting systems market CAGR (2022 to 2032) | 12.6% |
| Cell harvesting systems market Size 2022 | US$ 6.3 billion |
| Cell harvesting systems market Size 2032 | US$ 19.1 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The major drivers of market expansion for cell harvesting systems are rising investments in regenerative medicine and cell-based research, expanding biotechnology and biopharmaceutical sectors, and rising prevalence of infectious and chronic diseases.
Due to urbanization, sedentary lifestyles, changing diets, rising obesity rates, and widespread access to tobacco products, cancer, and heart disease are now the leading causes of death in developing economies. The primary driver of market expansion is the potential application of stem cells in the treatment of numerous chronic diseases. Therefore, it is anticipated that the incidence of chronic and infectious disorders will drive the cell harvesting systems market expansion.
The market for cell harvesting systems is anticipated to grow significantly as bone marrow transplant procedures become more prevalent due to rising rates of anemia and blood cancer. In addition, increased healthcare spending per capita, post-therapy survival, logistical facility investment, expansion of the cardiac bone marrow transplant registry, and neurological ailments are all important factors.
Principal Consultant
The cell harvesting systems market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
North America is the leading region in the global cell harvesting systems market due to increased study spending and public projects, frequent use of stem cells for the treatment of cancer patients, and increased healthcare spending.
Apart from North America, the European cell harvesting systems market is also expected to display lucrative growth in the projected years due growing geriatric population and the presence of major players in the industry.
The East Asian region is predicted to show lucrative growth owing to the growing rates of cardiovascular diseases coupled with the rising geriatric population.
Sartorius AG, Danaher Corporation, Cox Scientific Ltd., Thomas Scientific, Teleflex Inc, Argos Technologies Inc, Perkin Elmer Inc, Arthrex Inc., Avita Medical, Tomtec, erumo Corporation, and Bertin.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 12.6% 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion, Volume in Units, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segment Covered | Technology, Application, End User, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel |
| Key Players | Sartorius AG; Danaher Corporation; Cox Scientific Ltd.; Thomas Scientific; Teleflex Inc; Argos Technologies Inc; Perkin Elmer Inc; Arthrex Inc.; Avita Medical; Tomtec; Terumo Corporation; Bertin |
| Customization | Available Upon Request |
The market is likely to register a CAGR of 12.6% through 2032.
The market is currently valued at US$ 6.3 Bn in 2022.
The market is likely to grow to a valuation of US$ 19.1 Bn by 2032.
North America is likely to be a leading market during the forecast period.
Explore Healthcare Insights
View Reports
Cell Harvesting Systems Market
